InvestorsHub Logo
Followers 0
Posts 122
Boards Moderated 0
Alias Born 12/09/2011

Re: None

Thursday, 12/14/2017 11:02:45 PM

Thursday, December 14, 2017 11:02:45 PM

Post# of 50157
''In the United States, Delcath’s system for PHP has been evaluated in a Phase 3 trial for patients with unresectable ocular and cutaneous liver metastases. Additional cancers including colorectal cancer, neuroendocrine tumors and in patients with hepatocellular carcinoma (primary liver cancer) have been studied. These studies are presently being evaluated by the FDA.''

THAT'S Important !
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent DCTH News